Serina Therapeutics
Serina develops small molecules, RNA-based therapeutics, and antibody-drug conjugates for neurological diseases using its POZ Platform.
8-KSep 9Latest SEC filing, period to Sep 9
Aug 26Latest story
Sign inSign inSerina develops small molecules, RNA-based therapeutics, and antibody-drug conjugates for neurological diseases using its POZ Platform.
August 2026
July 2026